Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race, Ethnicity

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1990?guestAccessKey=3d042976-b580-42b8-a1f0-341ff4cef611&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322

 

About The Study: This study of 45,000 women assessed the risk of having no biopsy performed within 90 days of abnormal screening results by racial and ethnic group and evaluated how individual-, neighborhood- and health care-level factors affect the relationship between racial and ethnic group and delay.

Authors: Marissa B. Lawson, M.D., of the University of Washington School of Medicine in Seattle, is the corresponding author.

 

(doi:10.1001/jamaoncol.2022.1990)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.